SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Lightricks challenges AI giants with open-source text-to-video platform

Full list of Israeli high-tech funding rounds in 2024

TailorMed raises $40 million in equity and debt to help patients access critical medications

Why Israeli tech companies are moving to Miami

Buzz

Most popular

Daily

Weekly

1

Stars over Athens: The who’s who at Calcalist's first Israel-Greece conference

2

Wiz acquires Dazz for $450 million to strengthen AI-driven cloud security

3

Cyera doubles valuation to $3B with $300M Series D, total funding hits $600M in seven months

4

Mediaocean acquires Innovid for $500M, delisting it from the NYSE

5

Claroty veterans launch Twine with $12M in Seed funding from Dell and Wiz founders to deploy AI cyber workers

Anchiano

2 stories about Anchiano

הבורסה לניירות ערך רחוב אחוזת בית תל אביב

Anchiano Therapeutics Schedules TASE Delisting

14.03.19|Lilach Baumer

Based in Jerusalem and Cambridge, Massachusetts, clinical-stage Anchiano develops gene therapies for cancer, with a special focus on bladder cancer

Cancer Treatment Company Anchiano Therapeutics Wants to List on Nasdaq

09.01.19|Lilach Baumer

The company formerly known as BioCanCell submitted a prospectus to the SEC on Monday, with Oppenheimer & Co. as the sole underwriter